NO20042497L - 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse - Google Patents
4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disseInfo
- Publication number
- NO20042497L NO20042497L NO20042497A NO20042497A NO20042497L NO 20042497 L NO20042497 L NO 20042497L NO 20042497 A NO20042497 A NO 20042497A NO 20042497 A NO20042497 A NO 20042497A NO 20042497 L NO20042497 L NO 20042497L
- Authority
- NO
- Norway
- Prior art keywords
- difluoro
- tetrahydro
- salts
- benzazepine derivatives
- benzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001350909 | 2001-11-16 | ||
| JP2002252931 | 2002-08-30 | ||
| PCT/JP2002/011842 WO2003042181A1 (fr) | 2001-11-16 | 2002-11-13 | Derives de 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine, ou sels desdits derives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042497L true NO20042497L (no) | 2004-07-21 |
Family
ID=26624548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042497A NO20042497L (no) | 2001-11-16 | 2004-06-15 | 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7169772B2 (fr) |
| EP (1) | EP1445253B1 (fr) |
| JP (1) | JP4075064B2 (fr) |
| KR (1) | KR100632882B1 (fr) |
| CN (1) | CN1323076C (fr) |
| AT (1) | ATE438626T1 (fr) |
| AU (1) | AU2002349773B2 (fr) |
| BR (1) | BR0214224A (fr) |
| CA (1) | CA2464069A1 (fr) |
| DE (1) | DE60233251D1 (fr) |
| ES (1) | ES2327620T3 (fr) |
| HU (1) | HUP0402235A2 (fr) |
| MX (1) | MXPA04004501A (fr) |
| NO (1) | NO20042497L (fr) |
| PL (1) | PL369999A1 (fr) |
| RU (1) | RU2268882C1 (fr) |
| WO (1) | WO2003042181A1 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| ATE513838T1 (de) | 2002-09-20 | 2011-07-15 | Promega Corp | Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität |
| US7241803B2 (en) * | 2002-11-21 | 2007-07-10 | New York Blood Center | Compounds for inhibition of HIV infection by blocking HIV entry |
| AU2004234258B2 (en) | 2003-04-28 | 2009-04-09 | Tacurion | 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof |
| WO2005090282A1 (fr) | 2004-03-12 | 2005-09-29 | Ligand Pharmaceuticals Incorporated | Composes modulateurs de recepteur d'androgenes et procedes |
| EP1935986B1 (fr) | 2005-05-31 | 2014-04-16 | Promega Corporation | Composés luminogènes et fluorogènes et procédés pour la détection de molécules ou de conditions |
| EP2778234B1 (fr) | 2005-05-31 | 2017-09-27 | Promega Corporation | Composés luminogènes et fluorogènes et procédés pour la détection de molécules ou de conditions |
| KR101136183B1 (ko) | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | 신규 헤테로시클리덴 아세트아미드 유도체 |
| JP5164510B2 (ja) * | 2006-10-06 | 2013-03-21 | 日本曹達株式会社 | 含窒素複素環化合物および有害生物防除剤 |
| WO2008078725A1 (fr) | 2006-12-26 | 2008-07-03 | Daiichi Sankyo Company, Limited | Dérivé de thiazépine |
| PE20081692A1 (es) | 2007-01-24 | 2008-12-18 | Mochida Pharm Co Ltd | Nuevo derivado de heterocicliden acetamida |
| US20100016285A1 (en) * | 2007-01-24 | 2010-01-21 | Mochida Pharmaceutical Co., Ltd. | Heterocyclidene-n-(aryl) acetamide derivative |
| WO2008126899A1 (fr) * | 2007-04-11 | 2008-10-23 | Kissei Pharmaceutical Co., Ltd. | Dérivé hétérocyclique à 5 éléments et ses usages médicaux |
| JP5451613B2 (ja) | 2007-08-06 | 2014-03-26 | アラーガン、インコーポレイテッド | デスモプレシン薬物送達のための方法及びデバイス |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| ES2710454T3 (es) * | 2008-05-21 | 2019-04-25 | Ferring Bv | Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia |
| UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
| DK2860175T3 (da) | 2012-06-11 | 2018-01-29 | Tacurion | Fremgangsmåde til fremstilling af 4,4,7-trifluor-1,2,3,4-tetrahydro-5h-1-benzazepin-forbindelse og intermediat til syntese deraf |
| PL2940008T3 (pl) * | 2012-12-26 | 2017-10-31 | Sanwa Kagaku Kenkyusho Co | Nowa pochodna benzoazepiny i jej zastosowanie farmaceutyczne |
| US9790537B2 (en) | 2014-01-29 | 2017-10-17 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
| CN105310978A (zh) * | 2014-08-04 | 2016-02-10 | 李峰 | 一种含有活性成分盐酸考尼伐坦的药物组合物及其制剂 |
| CN112079826B (zh) * | 2020-09-17 | 2022-07-29 | 广州中医药大学(广州中医药研究院) | 一类甾体合成酶抑制剂及其治疗应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1039999A (zh) * | 1988-07-30 | 1990-02-28 | 刘晓非 | 多层复合装饰板及制作方法 |
| TW270927B (fr) | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| EP0716083A4 (fr) * | 1993-08-26 | 1996-08-28 | Yamanouchi Pharma Co Ltd | Derives de la benzazepine, composition pharmaceutique le contenant, et ses intermediaires |
| TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| JPH09221475A (ja) * | 1996-02-13 | 1997-08-26 | Yamanouchi Pharmaceut Co Ltd | 新規なオキシム誘導体 |
| AR011913A1 (es) | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
-
2002
- 2002-11-13 ES ES02781759T patent/ES2327620T3/es not_active Expired - Lifetime
- 2002-11-13 DE DE60233251T patent/DE60233251D1/de not_active Expired - Lifetime
- 2002-11-13 BR BR0214224-4A patent/BR0214224A/pt not_active IP Right Cessation
- 2002-11-13 CN CNB028226046A patent/CN1323076C/zh not_active Expired - Fee Related
- 2002-11-13 AT AT02781759T patent/ATE438626T1/de not_active IP Right Cessation
- 2002-11-13 RU RU2004118063/04A patent/RU2268882C1/ru not_active IP Right Cessation
- 2002-11-13 EP EP02781759A patent/EP1445253B1/fr not_active Expired - Lifetime
- 2002-11-13 CA CA002464069A patent/CA2464069A1/fr not_active Abandoned
- 2002-11-13 US US10/495,494 patent/US7169772B2/en not_active Expired - Fee Related
- 2002-11-13 AU AU2002349773A patent/AU2002349773B2/en not_active Ceased
- 2002-11-13 KR KR1020047007126A patent/KR100632882B1/ko not_active IP Right Cessation
- 2002-11-13 WO PCT/JP2002/011842 patent/WO2003042181A1/fr active Application Filing
- 2002-11-13 JP JP2003544017A patent/JP4075064B2/ja not_active Expired - Fee Related
- 2002-11-13 PL PL02369999A patent/PL369999A1/xx not_active Application Discontinuation
- 2002-11-13 HU HU0402235A patent/HUP0402235A2/hu unknown
- 2002-11-13 MX MXPA04004501A patent/MXPA04004501A/es active IP Right Grant
-
2004
- 2004-06-15 NO NO20042497A patent/NO20042497L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60233251D1 (de) | 2009-09-17 |
| BR0214224A (pt) | 2004-09-21 |
| US7169772B2 (en) | 2007-01-30 |
| WO2003042181A1 (fr) | 2003-05-22 |
| HUP0402235A2 (hu) | 2005-02-28 |
| EP1445253B1 (fr) | 2009-08-05 |
| ES2327620T3 (es) | 2009-11-02 |
| MXPA04004501A (es) | 2004-08-11 |
| PL369999A1 (en) | 2005-05-16 |
| CN1323076C (zh) | 2007-06-27 |
| EP1445253A1 (fr) | 2004-08-11 |
| RU2268882C1 (ru) | 2006-01-27 |
| CN1585752A (zh) | 2005-02-23 |
| KR100632882B1 (ko) | 2006-10-13 |
| JPWO2003042181A1 (ja) | 2005-03-10 |
| AU2002349773B2 (en) | 2007-12-13 |
| RU2004118063A (ru) | 2006-01-10 |
| CA2464069A1 (fr) | 2003-05-22 |
| EP1445253A4 (fr) | 2005-11-16 |
| US20050004103A1 (en) | 2005-01-06 |
| ATE438626T1 (de) | 2009-08-15 |
| KR20050044401A (ko) | 2005-05-12 |
| JP4075064B2 (ja) | 2008-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042497L (no) | 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse | |
| RS22104A (en) | Herbicide and safening combinations | |
| RS93604A (en) | Substituted phenylacetamides and their use as glucokinase activators | |
| MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
| RS50814B (sr) | Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena | |
| ATE410165T1 (de) | Nociceptin-analoga | |
| IL166483A0 (en) | Pharmaceutical compositions containing ciclesonideand an antihistamine | |
| PT1191025E (pt) | Cristais de lansoprazol | |
| SE9903759D0 (sv) | Pharmaceutically active compounds | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| DE59709788D1 (de) | Konjugat, umfassend einen Folsäureantagonisten und einen Träger | |
| NO20055602D0 (no) | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav | |
| EP0990635A4 (fr) | Hydroxycyclopentanone | |
| ITGE20020050A1 (it) | Procedimento per il trattamento di filati mediante agugliatura. | |
| TWI319321B (en) | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure | |
| HUP9904030A2 (hu) | Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására | |
| HRP20040186B1 (en) | Use of lhrh-antagonists for the improvement of t-cell mediated immunity | |
| ATE248168T1 (de) | Racemisierung von r,s-dioxo- benzylpyrrolopiperidin | |
| ATE182594T1 (de) | Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität | |
| ATE473970T1 (de) | N-substituiertes benzothiophensulfonamidderivat | |
| DE60228295D1 (de) | Chemische verbindungen | |
| YU83903A (sh) | Farmaceutske kombinacije zasnovane na derivatima piridoindolona | |
| ATE212504T1 (de) | Organische peroxoverbindungen enthaltendes mittel zur instrumentendesinfektion | |
| NO20041878D0 (no) | Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel. |